Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 September 2020 | Story Prof Felicity Burt | Photo Supplied
Prof Felicity Burt in front of the new state-of-the-art biosafety Level (BSL) 3 laboratory.

The University of the Free State’s (UFS) new biosafety Level (BSL) 3 laboratory will allow the university’s world-respected researchers to further advance their research on and surveillance of infectious pathogens, with the ultimate benefit being the improved quality of health for the communities of the Free State and beyond.

That is the word from two leading UFS academics on the completion of the new facility; the BSL 3 laboratory will further enhance the university’s reputation for high-level international research – especially in the field of human pathogens – which will help to prevent disease and lead to better health outcomes.

The UFS Vice-Rector of Research, Professor Corli Witthuhn, stressed how important it is to have a facility of this nature – the only one of its kind in central South Africa – on the Bloemfontein campus, noting that its relevance is even greater, its role more critical now that the world finds itself in the grip of the global COVID-19 pandemic.

Intensify research of the impact on human pathogens

“The new BSL 3 facility – the Pathogen Research Laboratory – promises to intensify our research of the impact on human pathogens, as it allows our South African Research Chairs (SARChl) and other outstanding researchers to broaden the range of microbial pathogens that are being studied, and gain a better understanding of the global disease burden,” she said.

Her sentiments were echoed by the university’s Dean of the Faculty of Health Sciences, Prof Gert van Zyl, who added that the international level of quality research carried out in this facility will contribute to improvement in the disease profile of central South Africa.

“In supporting partners like the Free State Department of Health, this important scientific footprint in disease prevention and treatment will benefit the community at large by improving the quality of health research and delivering the best possible outcomes.”

The BSL 3 facility is supported by a small suite of laboratories for molecular and serological research and is accessible to any UFS researcher or student requiring a high level of pathogen containment. 

Appropriate biosafety and containment measures

Research and handling of infectious viruses and bacteria require appropriate biosafety and containment measures to prevent laboratory workers, personnel, and the environment being exposed to potentially biohazardous agents. 

There are four distinct levels of biosafety (levels one to four), with each having specific biosafety requirements. A BSL 3 laboratory is designed and precision-built to operate under negative pressure, and sees all exhausted air passing through a dedicated filter system to ensure that no pathogens escape into the environment. In addition, researchers wear appropriate personal protective equipment suited to the pathogens under investigation.  

The UFS BSL 3 laboratory is a modular container supplied by Air Filter Maintenance Services International (AFMS) and comprises two repurposed shipping containers. It was built and factory-tested in Johannesburg before being dismantled and relocated to the Bloemfontein Campus, where the containers were lifted by crane over trees and onto a concrete platform. The AFMS installation team then spent a number of days metamorphosing the two containers into a state-of-the-art laboratory, with a mechanical plant room and the ducting that maintains the laboratory under constant negative pressure, cleverly and discretely disguised behind cladding, allowing the structure to blend in with neighbouring buildings.

The need for training young researchers and developing skills

The Pathogen Research Laboratory is managed by Professor Felicity Burt, an arbovirologist with more than 25 years’ experience in handling infectious viruses. 

“Biosafety and biosecurity are essential in the investigation of emerging and infectious pathogens that cause significant disease and fatalities,” Prof Burt said.

“And while COVID-19, pandemic, viruses, vaccines, masks, social distancing, and lockdown were words seldom heard just six months ago, they are sadly now part of our everyday vocabulary,” she added, explaining that the current pandemic is the result of the zoonotic transmission of a virus from a wild animal to humans, with subsequent global spread.

“As this is not the first pandemic and will not be the last, the ongoing potential for the emergence of novel viruses and bacteria underscores the need for training young researchers and developing skills to tackle future outbreaks, develop new vaccines, understanding how pathogens cause disease, and discover alternate ways to mitigate outbreaks. 

“We are thrilled to have a state-of-the-art laboratory that allows us to safely handle those pathogens previously excluded from our research and surveillance programme. This facility positions the UFS to provide young scientists with world-class training and build capacity, now and into the future.”

* Division of Virology, University of the Free State, and NHLS, Bloemfontein, South Africa

News Archive

The failure of the law
2004-06-04

 

Written by Lacea Loader

- Call for the protection of consumers’ and tax payers rights against corporate companies

An expert in commercial law has called for reforms to the Companies Act to protect the rights of consumers and investors.

“Consumers and tax payers are lulled into thinking the law protects them when it definitely does not,” said Prof Dines Gihwala this week during his inaugural lecture at the University of the Free State’s (UFS).

Prof Gihwala, vice-chairperson of the UFS Council, was inaugurated as extraordinary professor in commercial law at the UFS’s Faculty of Law.

He said that consumers, tax payers and shareholders think they can look to the law for an effective curb on the enormous power for ill that big business wields.

“Once the public is involved, the activities of big business must be controlled and regulated. It is the responsibility of the law to oversee and supervise such control and regulation,” said Prof Gihwala.

He said that, when undesirable consequences occur despite laws enacted specifically to prevent such results, it must be fair to suggest that the law has failed.

“The actual perpetrators of the undesirable behaviour seldom pay for it in any sense, not even when criminal conduct is involved. If directors of companies are criminally charged and convicted, the penalty is invariably a fine imposed on the company. So, ironically, it is the money of tax payers that is spent on investigating criminal conduct, formulating charges and ultimately prosecuting the culprits involved in corporate malpractice,” said Prof Gihwala.

According to Prof Gihwala the law continuously fails to hold companies meaningfully accountable to good and honest business values.

“Insider trading is a crime and, although legislation was introduced in 1998 to curb it, not a single successful criminal prosecution has taken place. While the law appears to be offering the public protection against unacceptable business behaviour, it does no such thing – the law cannot act as a deterrent if it is inadequate or not being enforced,” he said.

The government believed it was important to facilitate access to the country’s economic resources by those who had been denied it in the past. The Broad Based Economic Empowerment Act of 2003 (BBEE), is legislation to do just that. “We should be asking ourselves whether it is really possible for an individual, handicapped by the inequities of the past, to compete in the real business world even though the BBEE Act is now part of the law?,” said Prof Gihwala.

Prof Gihwala said that judges prefer to follow precedent instead of taking bold initiative. “Following precedent is safe at a personal level. To do so will elicit no outcry of disapproval and one’s professional reputation is protected. The law needs to evolve and it is the responsibility of the judiciary to see that it happens in an orderly fashion. Courts often take the easy way out, and when the opportunity to be bold and creative presents itself, it is ignored,” he said.

“Perhaps we are expecting too much from the courts. If changes are to be made to the level of protection to the investing public by the law, Parliament must play its proper role. It is desirable for Parliament to be proactive. Those tasked with the responsibility of rewriting our Companies Act should be bold and imaginative. They should remove once and for all those parts of our common law which frustrate the ideals of our Constitution, and in particular those which conflict with the principles of the BBEE Act,” said Prof Gihwala.

According to Prof Gihwala, the following reforms are necessary:

• establishing a unit that is part of the office of the Registrar of Companies to bolster a whole inspectorate in regard to companies’ affairs;
• companies who are liable to pay a fine or fines, should have the right to take action to recover that fine from those responsible for the conduct;
• and serious transgression of the law should allow for imprisonment only – there should be no room for the payment of fines.
 

Prof Gihwala ended the lecture by saying: “If the opportunity to re-work the Companies Act is not grabbed with both hands, we will witness yet another failure in the law. Even more people will come to believe that the law is stupid and that it has made fools of them. And that would be the worst possible news in our developing democracy, where we are struggling to ensure that the Rule of Law prevails and that every one of us has respect for the law”.

 

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept